These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 19283791)

  • 1. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.
    Hartman A; te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Kemper HC; Hop WC; van den Heuvel-Eibrink MM; Pieters R
    Pediatr Blood Cancer; 2009 Jul; 53(1):64-71. PubMed ID: 19283791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
    van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
    J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
    van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
    Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
    J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
    Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
    Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise effects on bone mineral density relationships to changes in fitness and fatness.
    Stewart KJ; Bacher AC; Hees PS; Tayback M; Ouyang P; Jan de Beur S
    Am J Prev Med; 2005 Jun; 28(5):453-60. PubMed ID: 15894149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
    Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
    Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
    Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R
    Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of birth size and body composition on bone mineral density in early adulthood: the PROGRAM study.
    Leunissen RW; Stijnen T; Boot AM; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):386-92. PubMed ID: 18284639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in peripheral muscle strength and ankle dorsiflexion as long-term side effects of treatment for childhood cancer.
    Hartman A; van den Bos C; Stijnen T; Pieters R
    Pediatr Blood Cancer; 2008 Apr; 50(4):833-7. PubMed ID: 17763466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatine monohydrate attenuates body fat accumulation in children with acute lymphoblastic leukemia during maintenance chemotherapy.
    Bourgeois JM; Nagel K; Pearce E; Wright M; Barr RD; Tarnopolsky MA
    Pediatr Blood Cancer; 2008 Aug; 51(2):183-7. PubMed ID: 18421708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mass and body composition after cessation of therapy for childhood cancer.
    Nysom K; Mølgaard C; Holm K; Hertz H; Michaelsen KF
    Int J Cancer Suppl; 1998; 11():40-3. PubMed ID: 9876476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal morbidity in childhood acute lymphoblastic leukemia.
    Mandel K; Atkinson S; Barr RD; Pencharz P
    J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of exercise vs bisphosphonates on bone mineral density in breast cancer patients receiving chemotherapy.
    Swenson KK; Nissen MJ; Anderson E; Shapiro A; Schousboe J; Leach J
    J Support Oncol; 2009; 7(3):101-7. PubMed ID: 19507458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy.
    Kelly KM; Thornton JC; Hughes D; Osunkwo I; Weiner M; Wang J; Horlick M
    Pediatr Blood Cancer; 2009 Jan; 52(1):33-8. PubMed ID: 18816694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone mineral density in children before and after completion of cancer treatment].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Kaczmarski M; Piotrowska-Jastrzebska J
    Pol Merkur Lekarski; 2004 Jul; 17(97):37-42. PubMed ID: 15559608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
    Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
    J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.